118291-90-0

Basic information

• Product Name: 2-chloro-4-nitrophenylmaltotrioside
• Synonyms: 2-chloro-4-nitrophenylmaltotrioside;2-Chloro-4-nitrophenyl a-D-maltotrioside;2-Chloro-4-nitrophenyl alpha-maltotrioside;4)-alpha-D-glucopyranoside;2-Chloro-4-nitrophenyl O-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyranosyl-(1-4)-alpha-D-glucopyranoside;CNPG3
• CAS NO: 118291-90-0
• Molecular Formula: C24H34ClNO18
• Molecular Weight: 659.975
• EINECS: 1533716-785-6
• Mol File: 118291-90-0.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 973°Cat760mmHg
• Flash Point: 542.2°C
• Appearance: /
• Density: 1.84g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.711
• Storage Temp.: Hygroscopic, -20°C Freezer, Under inert atmosphere
• Solubility: Water (Slightly)
• PKA: 12.44±0.70(Predicted)
• CAS DataBase Reference: 2-chloro-4-nitrophenylmaltotrioside(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-4-nitrophenylmaltotrioside(118291-90-0)
• EPA Substance Registry System: 2-chloro-4-nitrophenylmaltotrioside(118291-90-0)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 118291-90-0(Hazardous Substances Data)

Usage

Description

2-chloro-4-nitrophenylmaltotrioside, also known as 2-chloro-4-nitrophenyl-α-D-maltotrioside, is a synthetic compound that serves as a substrate for the determination of enzymatic activity of α-amylase. It is characterized by its white crystalline or flaky appearance and is widely utilized in various applications across different industries.

Uses

Used in Enzyme Assays:
2-chloro-4-nitrophenylmaltotrioside is used as a substrate in enzyme assays for the measurement of α-amylase activity. It is particularly useful in the detection and quantification of this enzyme, which plays a crucial role in the breakdown of starch into simpler sugars.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-chloro-4-nitrophenylmaltotrioside is used as a diagnostic tool for the assessment of α-amylase levels in patients. This is important for the diagnosis and monitoring of various conditions, such as pancreatitis and other pancreatic disorders, where α-amylase levels may be elevated.
Used in Research and Development:
2-chloro-4-nitrophenylmaltotrioside is also employed in research and development for the study of α-amylase and its role in various biological processes. It aids in understanding the enzyme's function, regulation, and potential therapeutic applications.
Used in Quality Control:
In the food and beverage industry, 2-chloro-4-nitrophenylmaltotrioside is used as a quality control tool to assess the effectiveness of α-amylase in the breakdown of starch during the production of various products, such as bread, beer, and other fermented goods.

InChI:InChI=1/C24H34ClNO18/c25-9-3-7(26(38)39)1-2-8(9)24(44-23-20(37)17(34)14(31)11(5-28)41-23)21(18(35)15(32)12(6-29)43-24)42-22-19(36)16(33)13(30)10(4-27)40-22/h1-3,10-23,27-37H,4-6H2/t10-,11-,12-,13-,14-,15-,16+,17+,18+,19-,20-,21-,22-,23-,24-/m1/s1

Upstream product

• 90826-64-5 2-chloro-4-nitrophenyl β-maltoheptoside 
• 99304-80-0 2-chloro-4-nitrophenyl-β-maltopentoside 
• 145072-72-6 o-chloro-p-nitrophenyl β-maltotetraoside 
• 198561-63-6 2-chloro-4-nitrophenyl O-(α-D-glucopyranosyl)-(1->4)-tetrakis-[O-α-D-glucopyranosyl-(1->4)]-β-D-glucopyranoside 
• 76821-27-7 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl-(1->4)-2,3,6-tri-O-acetyl-α-D-glucopyranosyl-(1->4)-2,3,6-tri-O-acetyl-α-D-glucopyranosyl-bromide 
• 619-08-9 2-chloro-4-nitrophenol 
• 61139-07-9 1,2,3,6-tetra-O-acetyl-4-O-(2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl)-α-D-glucopyranosyl)-D-glucopyranose 
• 1512800-77-9 C₄₈H₇₄ClNO₃₈ 

Downstream Products

• 6401-81-6 maltotriose 
• 619-08-9 2-chloro-4-nitrophenol 
• 492-61-5 β-D-glucose 
• 1554036-64-4 4,6-O-benzylidene-2-chloro-4-nitrophenyl cellotrioside 

Relevant articles and documents

Chemoenzymatic preparation of 2-chloro-4-nitrophenyl β-maltooligosaccharide glycosides using glycogen phosphorylase b

In the present work, we aimed to develop a new chemoenzymatic procedure for the synthesis of β-maltooligosaccharide glycosides. The primer in the enzymatic reaction was 2-chloro-4-nitrophenyl β-maltoheptaoside (G7-CNP), which was synthesised from β-cyclodextrin (β-CD) using a very convenient chemical method [E. Farkas, L. Janossy, J. Harangi, L. Kandra, A. Liptak, Carbohydr. Res., 303 (1997) 407-415]. Shorter chain length CNP-maltooligosaccharides in the range of dp 3-6 were prepared using rabbit skeletal muscle glycogen phosphorylase b (EC 2.4.1.1). Detailed enzymological investigations revealed that the conversion of G7-CNP was highly dependent on the conditions of phosphorolysis. A 100% conversion of G7-CNP was achieved during 10 min in 1 M phosphate buffer (pH 6.8) at 30°C with the tetramer glycoside (77%) as the main product. Phosphorolysis at 10°C for 10 min resulted in 89% conversion and G4-, G5-, and G6-CNP oligomers were detected in the ratio of 29:26:34%, respectively. The reaction pattern was investigated using an HPLC system. The preparative scale isolation of G(3→6)-CNP glycosides was achieved by size-exclusion column chromatography (SEC) on Toyopearl HW-40 matrix. The productivity of the synthesis was improved by yields of up to 70-75%. Copyright (C) 1999 Elsevier Science Ltd.

Examination of the active sites of human salivary α-amylase (HSA)

The action pattern of human salivary amylase (HSA) was examined by utilising as model substrates 2-chloro-4-nitrophenyl (CNP) β-glycosides of maltooligosaccharides of dp 4-8 and some 4-nitrophenyl (NP) derivatives modified at the nonreducing end with a 4,6-O-benzylidene (Bnl) group. The product pattern and cleavage frequency were investigated by product analysis using HPLC. The results revealed that the binding region in HSA is longer than five subsites usually considered in the literature and suggested the presence of at least six subsites; four glycone binding sites (-4, -3, -2, -1) and two aglycone binding sites (+1, +2). In the ideal arrangement, the six subsites are filled by a glucosyl unit and the release of maltotetraose (G4) from the nonreducing end is dominant. The benzylidene group was also recognisable by subsites (-3) and (-4). The binding modes of the benzylidene derivatives indicated a favourable interaction between the Bnl group and subsite (-3) and an unfavourable one with subsite (-4). Thus, subsite (-4) must be more hydrophylic than hydrophobic. As compared with the action of porcine pancreatic α-amylase (PPA) on the same substrates, the results showed differences in the three-dimensional structure of active sites of HSA and PPA. (C) 2000 Elsevier Science Ltd.